Skip to content

Distal Pancreatectomy A randomized controlled trial to compare two different surgical techniques

Distal Pancreatectomy A randomized controlled trial to compare two different surgical techniques - DISPACT-TRIAL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON30759
Enrollment
45
Registered
2007-04-23
Start date
2007-05-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

leftsided resection pancreas

Interventions

1. Scalpel transsection of the pancreas and hand-sewn closure of the pancreatic remnant 2. Stapler-transsection of the pancreas and stapler-closure of the pancreatic remnant

Sponsors

Chirurgische Universitätsklinik Heidelberg Duitsland
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: · Age equal or above 18 years · Expected survival time more than 12 months · Patients with at least one of the following pathologic diseases scheduled for elective resection: - Resectable malignancies of the pancreatic body and/or tail - Resectable chronic pancreatitis of the body and/or tail - Resectable benign tumours of the pancreas including neuroendocrine tumours - Resectable pseudocyst of the pancreatic body and/or tail

Exclusion criteria

Exclusion criteria: · Current immunosuppressive therapy · Chemotherapy within 2 weeks before operation · Radiotherapy within 8 weeks before operation · Curative resection is not feasible · Severe psychiatric or neurologic diseases · Drug- and/or alcohol-abuse according to local standards · Participation in another intervention-trial with interference of intervention or outcome · Inability to follow the instructions given by the investigator or interviewer · Expected lack of compliance · Lack of informed consent

Design outcomes

Primary

MeasureTime frame
Combined primary endpoint: · Occurence of a pancreatic fistula. · Death due to any cause until the postoperative day 7.

Secondary

MeasureTime frame
1. Surgical category · Operating time [min] from resection to beginning of closure of the abdomen · Total operating time [min] · Frequency of burst abdomen · Frequency of wound infection · Frequency of intra-abdominal fluid collection rated as abscess that requires an intervention (surgery, drainage, antibiotic treatment) 2. Non-surgical category · postoperative length of hospital stay · Frequency of new onset diabetes mellitus (necessity of new anti-diabetic drug treatment) · One-year survival

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)